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GM-CSF Regulates
Alveolar Macrophage Differentiation
and Innate Immunity in the Lung through PU.1
AMs are not known but are of fundamental significance
because of the critical and diverse roles of these cells.
Granulocyte macrophage-colony stimulating factor
(GM-CSF) promotes the survival, differentiation, prolifer-
ation, and function of myeloid progenitors (Rasko, 1994)
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as well as the proliferation and function of AMs (Aka-Cincinnati, Ohio 45229
gawa et al., 1988; Chen et al., 1988) and pulmonary type
II alveolar epithelial cells (Huffman Reed et al., 1997).
An unexpected but critical role for GM-CSF in lung ho-Summary
meostasis was revealed by ablation of murine loci for
GM-CSF (GM/ mice) (Dranoff et al., 1994) or its recep-GM-CSF gene targeted (GM/) mice are susceptible
tor (GM Rc/ mice) (Robb et al., 1995), both of whichto respiratory infections and develop alveolar pro-
result in pulmonary alveolar proteinosis (PAP) and ab-teinosis due to defects in innate immune function and
normalities of AM function. AM abnormalities in GM/surfactant catabolism in alveolar macrophages (AMs),
mice include (1) surfactant accumulation (Dranoff et al.,respectively. Reduced cell adhesion, phagocytosis,
1994) due to decreased catabolism of surfactant lipidspathogen killing, mannose- and Toll-like receptor ex-
and proteins by AMs (Ikegami et al., 1996; Yoshida etpression, and LPS- or peptidoglycan-stimulated TNF
al., 2001); (2) defective phagocytosis of fungi (Paine etrelease were observed in AMs from GM/ mice. The
al., 2000); and (3) decreased oxygen radical productiontranscription factor PU.1 was markedly reduced in
(LeVine et al., 1999). GM/ mice have defective pulmo-AMs of GM/ mice in vivo and was restored by selec-
nary clearance of bacterial or fungal pathogens and in-tive expression of GM-CSF in the lungs of SPC-GM/
creased susceptibility and abnormal cytokine re-
GM/ transgenic mice. Retrovirus-mediated expres-
sponses to lung infection (LeVine et al., 1999). These
sion of PU.1 in AMs from GM/ mice rescued host
defects are corrected by pulmonary administration of
defense functions and surfactant catabolism by AMs.
GM-CSF or by expression of GM-CSF in the lungs either
We conclude that PU.1 mediates GM-CSF-dependent
by somatic gene transfer or in transgenic mice utilizing
effects on terminal differentiation of AMs regulating a lung-specific transgene (SPC-GM/GM/ mice) (Huff-
innate immune functions and surfactant catabolism man et al., 1996; Reed et al., 1999; Zsengeller et al.,
by AMs. 1998). In GM Rc/ mice, correction of PAP by bone
marrow transplantation suggested that disturbance of
Introduction an effect of GM-CSF on AMs rather than type II alveolar
epithelial cells is responsible for PAP in this model (Ni-
The alveolar macrophage (AM) has a critical role in both shinakamura et al., 1996b). These data demonstrate that
lung host defense and surfactant homeostasis. AMs GM-CSF regulates diverse functions of AMs critical to
contribute to innate immunity in the lung by virtue of surfactant homeostasis and host defense; however, the
their ability to migrate, phagocytose, and kill microor- mechanism(s) by which this occurs are not known.
ganisms, and recruit and activate other inflammatory PU.1 is an ets-family transcription factor that regulates
myeloid and B cell lineage development (Klemsz et al.,cells. Macrophages also provide important links be-
1990; Scott et al., 1994). PU.1 gene disruption abolishestween innate and adaptive immunity—for example, by
macrophage and B lymphocyte production and delaysToll-like receptor-mediated pathogen recognition that
neutrophils and T lymphocyte production (Scott et al.,results in release of cytokines capable of reprogram-
1994; McKercher et al., 1996). Although not essentialming other innate and adaptive immune responses (Ad-
for myeloid lineage commitment (Olson et al., 1995),erem and Ulevitch, 2000). AMs are vital to normal lung
PU.1 promotes both the proliferation (Celada et al., 1996)surfactant metabolism, to which they contribute by ca-
and differentiation (DeKoter et al., 1998) of myeloid pro-tabolism of both surfactant lipids and surfactant pro-
genitors. Recently, GM-CSF and PU.1 have been pro-teins (Yoshida et al., 2001). Although AMs originate from
posed to have distinct roles in late-stage myeloid devel-hematopoietic stem cells in bone marrow (Thomas et al.,
opment, with GM-CSF promoting cell proliferation and1976), they are predominantly derived from circulating
PU.1 promoting differentiation (Anderson et al., 1999).blood monocytes (Kennedy and Abkowitz, 1998) which
To discern the role of GM-CSF and PU.1 in mechanismsenter the lung and other tissues and differentiate into
regulating AM terminal differentiation and developmentmorphologically, histochemically, and functionally dis-
of normal innate immune function in the lung, AMs fromtinct tissue macrophage populations (Hume et al., 1983).
GM/, GM/, and SPC-GM/GM/ mice were studiedThe mechanisms mediating terminal differentiation of
in vivo and in vitro. Results showed that GM-CSF stimu-
lated PU.1 protein levels in AMs in vivo and that the
2 Correspondence: bruce.trapnell@chmcc.org absence of PU.1 in AMs strongly correlated with func-
3 Present address: Department of Biochemistry, University of Texas
tional defects in AMs, including decreased surfactantHealth Center at Tyler, Tyler, Texas 75708.
catabolism, cell adhesion, phagocytosis, bacterial killing,4 Present address: Department of Molecular Medicine, Graduate
pathogen recognition receptor expression, and inflam-School of Medicine, Osaka University, Suita, Osaka 565-0821,
Japan. matory cytokine signaling. Importantly, retrovirus-medi-
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ated PU.1 expression in AMs of GM/ mice rescued or
stimulated all of these functions. We conclude that GM-
CSF stimulates terminal differentiation of AMs predomi-
nately through PU.1 and, in so doing, regulates critical
components of the innate immune system in the lung.
Results
GM-CSF Increases PU.1 Levels in AMs In Vivo
GM/ and SPC-GM/GM/ mice were generated pre-
viously (Dranoff et al., 1994; Huffman et al., 1996). GM-
CSF is absent in GM/ mice, while in SPC-GM/GM/
mice GM-CSF is detectable at high levels in the lungs
but not blood, (Huffman et al., 1996) and in GM/ mice
it is detectable in the lungs but only at low levels (Paine
et al., 2000). For clarity and ease of presentation, AMs
from various sources will be referenced by subscripts
that indicate the relevant genetic manipulation of mice
from which they were derived, i.e., AMGM/, AMGM/,
and AMSPC-GM/GM/ designate primary AMs from GM/,
GM/, and SPC-GM/GM/mice, respectively. Western
analysis was used to assess the role of GM-CSF in
regulating PU.1 levels in primary AMs (Figure 1A). PU.1
Figure 1. GM-CSF Regulates PU.1 Expression in Alveolar Macro-was readily detected in AMGM/, absent in AMGM/, and
phageswas rescued in AMSPC-GM/GM/, where levels were higher
(A) PU.1 was assessed by Western blotting in primary alveolar mac-than wild-type controls. To obtain data from primary
rophages (AM) from mice in which endogenous GM-CSF expressionAMs completely free of extracellular alveolar proteinosis
is normal (/, lane 1), absent due to gene targeting (/, lane 2),
material, primary AMs were adhered to plastic dishes or expressed only in the lungs of GM-CSF gene-ablated mice from
for 1 hr and gently but extensively washed prior to lysis a lung-specific promoter-driven transgene (/ SPC-GM, lane 3).
PU.1 was also assessed in cultured AM cell lines established fromfor Western analysis. PU.1 was present in AMGM/, was
GM/ mice transduced with a control retroviral vector (/, laneincreased in AMSPC-GM/GM/, and was present only in trace
4) or with a PU.1-expressing vector (/ PU.1, lane 5), or an AMamounts in AMGM/ (Figure 1B). Thus, PU.1 was de- cell line derived from wild-type (GM/, lane 6) mice. Actin controls
tected in primary AMs only in the presence of GM-CSF, are shown.
and local GM-CSF levels in lung correlated with PU.1 (B) To eliminate alveolar proteinosis material from the preparations,
primary AMs were adhered to plastic dishes for 1 hr prior to celllevels in AMs. M-CSF was quantified by enzyme-linked
lysis for Western blotting analysis.immunosorbent assay (Shibata et al., 2001) to evaluate
(C) M-CSF levels were quantified in unconcentrated lung lavageits potential role in AM terminal differentiation in this
fluid of GM/, GM/, and SPC-GM/GM/ mice (n  8, 8, and 4,
model. As expected, M-CSF was present in the lungs respectively) by ELISA.
of GM/ mice (Figure 1C). However, M-CSF levels were
significantly elevated in the lungs of GM/ mice com-
pared to controls (p  0.001) and normalized by lung- Forced Expression of PU.1 in AMs from GM/ Mice
specific GM-CSF expression in SPC-GM/GM/ mice. Rescues Macrophage Morphology and Cell Adhesion
These results show that the differentiation defect (see Primary AMGM/ had a characteristic large, foamy ap-
below) in GM/ mice is selectively restored by GM- pearance due to intracellular accumulation of surfactant
CSF/PU.1 and not by M-CSF in SPC-GM/GM/ mice. lipids and protein in vivo, findings that were corrected
Together, these results demonstrate that local GM-CSF in AMSPC-GM/GM/ (Figure 2A). Cultured AMGM//GFP were
expression within the lung regulates PU.1 levels in AMs large and flat with homogenously staining cytoplasm.
in vivo. We next evaluated the effect of forced PU.1 expres- Forced PU.1 expression rescued a macrophage-like
sion in AMs from GM/ mice using an AM cell line (mAM) phenotype consisting of a rounded shape, smaller size,
derived from GM/ mice (Z.C.C., unpublished data). and increased vacuolization, as seen in AMGM//PU.1.
These cells were transduced with retroviral vectors ex- Morphometric analysis of cultured AMs revealed that
pressing either PU.1 and green fluorescent protein ([GFP] PU.1 significantly reduced the cell diameter from 23.5 
as a selectable marker) or GFP alone (as a negative control) 0.5 to 14.5  0.28 m (p  0.00001) (Figure 2B). Adher-
as previously described (DeKoter and Singh, 2000) to gen- ence was reduced in AMGM//GFP, consistent with the
erate cell lines designated AMGM//PU.1 and AMGM//GFP, known effect of GM-CSF on primary myeloid cells (Ar-
respectively. An AM cell line previously established from naout et al., 1986), but was significantly increased by
GM/ mice (designated AMGM//MHS) with phagocytic and PU.1 (p  0.001) (Figure 2C).
bacteriocidal activity typical of normal AMs (Mbawuike
and Herscowitz, 1989) served as an additional positive Expression of PU.1 in AMs from GM/ Mice Rescues
control. PU.1 was expressed at high levels in AMGM//MHS Surfactant Catabolism
and also in AMGM//PU.1 but not in AMGM//GFP (Fig- To determine the role of PU.1 in surfactant catabolism by
AMs, we assessed uptake and degradation of surfactanture 1A).
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lipids and surfactant protein A (SP-A) in cultured AMs
derived from GM/ in the absence or presence of forced
PU.1 expression. AMGM//MHS demonstrated easily de-
tectable uptake of natural surfactant labeled with rho-
damine-conjugated dipalmitoylphosphatidylethanol-
amine (R-DPPE) as previously demonstrated for primary
AMGM/ (Yoshida et al., 2001) (Figure 3A). Although
AMGM//GFP failed to internalize R-DPPE, expression of
PU.1 in AMGM//PU.1 rescued R-DPPE uptake. To deter-
mine the role of PU.1 in surfactant lipid degrada-
tion, AMGM//GFP or AMGM//PU.1 were incubated with
1-2-phosphatidyl[N-methyl-3H]choline,1,2-dipalmitoyl
([3H]DPPC) and then evaluated for [3H]DPPC breakdown
products. PU.1 partially restored surfactant lipid degra-
dation, albeit not to levels seen in primary AMGM/ (Fig-
ure 3B). The role of PU.1 in stimulating catabolism of
surfactant protein was evaluated by quantifying uptake
and degradation of [125I]-labeled SP-A in these cells.
Both uptake and degradation of [125I]-labeled SP-A
was significantly reduced in AMGM//GFP compared to
AMGM/ (p  0.001) (Figure 3C). Although the effect of
PU.1 on SP-A uptake was mild, it normalized SP-A
catabolism; SP-A degradation in AMGM//PU.1 was sig-
nificantly increased compared to AMGM//GFP (p 0.01).
These data demonstrate that PU.1 partially corrects ab-
normalities of uptake and degradation of surfactant lipid
and restores SP-A catabolism in AMs of GM/ mice.
PU.1 Rescues Phagocytosis and Bacterial Killing
in AMs from GM/ Mice
To quantify the phagocytic capacity of AMs in vivo,
FITC-labeled latex beads were administered intratra-
cheally to GM/ or GM/ mice, and AMs were recov-
ered 6 hr later and assessed by FACS analysis. AMGM/
demonstrated a 3 log increase in the single peak of
fluorescence after bead administration (Figure 4A). In
contrast, the majority of AMs from GM/ mice showed
minimal fluorescence enhancement, and only a small
population showed a 2 log enhancement. Similar evalua-
tion of cultured AMGM/ in vitro showed only a small
increase in mean fluorescence after bead administration
(Figure 4A). Expression of PU.1 in AMGM//PU.1 stimu-Figure 2. Rescue of a Normal AM Phenotype by GM-CSF Overex-
lated a 2 log increase in mean fluorescence of all cellspression in the Lung In Vivo or Retrovirus-Mediated PU.1 Expression
In Vitro after bead administration compared to cells in the ab-
sence of beads. Phagocytosis of specific pathogens(A) Morphology of primary AMs from GM/ mice (left), GM/ mice
(middle), and SPC-GM/GM/ mice (right). Note the increased sur- and latex beads in cultured AMs was also evaluated by
factant accumulation in AMGM/ but not AMGM/ or AMSPC-GM/GM/. fluorescence microscopy. AMGM//MHS avidly phagocy-
Cytospin preparations were stained with Diff-Quick and evaluated tosed fluorescently labeled gram-negative and gram-
by light microscopy. Original magnification is 100; bar represents
positive bacteria (E. coli, S. aureus, respectively), yeast20 m.
particles (zymosan), and latex beads (Figure 4B). In con-(B) The top panels show morphology of cultured AMs from GM/
trast, cultured AMGM//GFP demonstrated little phago-mice after retroviral transduction with a control vector (left) or PU.1-
expressing vector (right). Note increased vacuolization induced by cytic uptake of either bacteria or zymosan and markedly
PU.1. Cells were collected after brief trypsinization and prepared reduced uptake of fluorescent beads. Forced PU.1 ex-
as above. The bottom panels show morphology of cells viewed by pression rescued specific and nonspecific phagocytosis
phase contrast microscopy of live cultures. Original magnification
in AMGM//PU.1.is 100 (top) or 40 (bottom); bar represents 20 m.
Bacteriocidal activity was assessed in AMs express-(C) In the top panel, the equivalent cell diameter of live cultured
ing or lacking PU.1 by incubating cultured AMs withAMs from GM/ mice transduced with a control vector (black) or
PU.1-expressing vector (hatched) was determined by morphometry live E. coli or group B Streptococcus. Because of differ-
as described in Experimental Procedures. In the bottom panel, to ences in phagocytic capacity, the data were normalized
measure the effect of PU.1 on adhesion of cultured AMs derived for the phagocytic index of AMGM//MHS, AMGM//GFP,from GM/ mice, cells transduced with control (black) or PU.1-
AMGM//PU.1 for each organism. The phagocytic indexexpressing (hatched) vectors were seeded in ultra-low adherence
for live E. coli and group B Streptococcus in these cellplastic dishes. Adherence was quantified 2 hr later by removal of
lines (see Experimental Procedures) was 181, 1, 62 andnonadherent cells by washing and enumerating adherent cells visu-
alized by fluorescence microscopy at 10 magnification. 70, 3, 44, respectively, consistent with the relative levels
Immunity
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Figure 3. Defective Surfactant Catabolism in
AMs of GM/ Mice and Rescue by Retrovi-
rus-Mediated PU.1 Expression
(A) To evaluate surfactant lipid uptake, cul-
tured AMs (as described in the legend to Fig-
ure 1) were incubated with natural surfactant
fluorescently labeled with rhodamine-DPPE
for 1 hr. Cells were then washed and visual-
ized by fluorescence microscopy using a rho-
damine filter to detect R-DPPE (top), by
phase microscopy to visualize cells (middle),
or with a FITC filter to detect expression of the
vector marker gene, GFP (bottom). Original
magnification is 20.
(B) To evaluate surfactant lipid degradation,
primary wild-type AMs (open bar) or cultured
AMs transduced with a control vector (black
bar) or PU.1-expressing vector (hatched bar)
were incubated with natural surfactant sus-
pension containing 100 g/ml [3H]DPPC as
described in the Experimental Procedures.
The degradation of [3H]DPPC by AMs was
estimated by measuring the generation of ra-
dioactive products partitioning in the water/
methanol phase during extraction from both
supernate and cells.
(C) To evaluate SP-A uptake, cultured AMs
(as above) were incubated with [125I]SP-A
(1 g/ml, 37	C, 4 hr). Total uptake was calcu-
lated from the sum of degradation products in
the media and cell-associated radioactivity.
Degradation products were calculated as the
amount of TCA-soluble radioactivity in the
media.
of phagocytic uptake demonstrated for these cells by fluo- Shepherd, 1995) or in proinflammatory cytokine signal-
ing responses to components of the gram-negative (e.g.,rescence microscopy (Figure 4A). As a positive control,
AMGM//MHS demonstrated strong killing activity against LPS) and gram-positive (e.g., peptidoglycan) cell walls
both organisms (Figure 5). In contrast, AMGM//GFP had (e.g., Toll-like Receptor [TLR] 4 and TLR2, respectively)
significantly less killing capacity for both organisms. (Aderem and Ulevitch, 2000; Wang et al., 2000). To as-
PU.1 restored the killing capacity for both organisms, sess the role of GM-CSF in regulation of these pathways,
as demonstrated in AMGM//PU.1. These data show that we used reverse transcription and polymerase chain
expression of PU.1 significantly stimulated pathogen reaction (RT-PCR) amplification to quantify expression
killing independently of its effects on phagocytic uptake of mRNA for MR, TLR2, and TLR4 (Figure 6). mRNA for
of the two organisms. MR, TLR2, and TLR4 were readily detectable in AMGM/
(Figure 6A). In contrast, MR mRNA was undetectable
and TLR2 and TLR4 mRNA levels were markedly reducedGM-CSF and PU.1 Rescue Cell-Surface Receptor
in primary AMGM/. Expression of GM-CSF in the lungs ofExpression in AMGM/
SPC-GM/GM/ mice restored mRNA levels for all threeAMs express multiple cell-surface receptors that are in-
receptors in AMSPC-GM/GM/. Similar to the data for primaryvolved in the phagocytic internalization of microorgan-
isms (e.g., the mannose receptor [MR]) (Chroneos and AM, mRNA for MR was absent and mRNA for TLR2 and
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Figure 4. Defective Phagocytosis in AMs of
GM/ Mice and Rescue by Expression of PU.1
(A) FACS analysis of AMs before and after
exposure to fluorescent latex beads in vivo
and in vitro. Left panels: to assess the effect
of GM-CSF on phagocytosis by AMs in vivo,
FITC-labeled latex beads were administered
to the lungs of GM/ or GM/ mice, and
primary AMs were recovered after 6 hr and
evaluated by flow cytometry. Right panels: to
assess the effect of PU.1 on phagocytosis by
AMs of GM/ mice in vitro, cultured AMs
transduced with a control vector (/) or a
PU.1-expressing vector (/ PU.1), were
exposed to FITC-labeled latex beads and
evaluated by flow cytometry. Dot plots show
forward scatter versus side scatter and the
gate used for primary AMs, and histograms
show FITC fluorescence versus cell number
(shaded curve). Each histogram includes a
curve on the left (black line) which shows
background autofluorescence of the cells in
the absence of beads.
(B) Assessment of phagocytosis in cultured
AMs by fluorescence microscopy. Cultured
AMs from GM/ mice (left panels) or from
GM/ mice transduced with either a control
(middle panels) or a PU.1-expressing vector
(right panels) were evaluated for phagocytic
uptake of various pathogens or particles (red-
orange color) as indicated. Phase contrast
views of GM/ cells are included for cell visual-
ization; retroviral-transduced AMs from GM/
mice were visualized by green fluorescence
of the GFP marker expressed from control or
PU.1 vectors. Original magnification is 40;
bar represents 20 m.
TLR4 was reduced in cultured AMGM//GFP (Figure 6A). cytokines (Basu et al., 1997), we evaluated the effect
of LPS on cytokine release by AMGM//GFP andImportantly, expression of PU.1 in AMGM//PU.1 rescued
expression of all three receptors. AMGM//PU.1 (Figure 6B). LPS failed to stimulate TNF

release from AMGM//GFP at any dose and only stimu-
lated very low level IL-6 release at high LPS doses. InPU.1 Rescues Toll-Like Receptor Signaling in AMs
from GM/ Mice marked contrast, expression of PU.1 in AMGM//PU.1
rescued dose-dependent, LPS-stimulated TNF
 andGram-negative bacteria stimulate secretion of proinflam-
matory cytokines from macrophages through interaction IL-6 secretion that was significantly higher than
AMGM//GFP at all doses tested (p  0.001). Since TLR2of lipopolysaccharide (LPS) with LPS binding protein,
which then signals through a cellular pathway involving is involved in stimulation of proinflammatory cytokine
signaling by gram-positive bacteria (Underhill et al.,CD14, TLR4, and MyD88, ultimately increasing expres-
sion of NFB-regulated genes such as TNF
 and IL-6 1999), we also evaluated the effect of peptidoglycan
on cytokine release. Peptidoglycan stimulated dose-(Aderem and Ulevitch, 2000). Since GM/ mice have re-
duced susceptibility to LPS-induced shock as well as dependent TNF
 release by AMGM//GFP (Figure 6B).
However, expression of PU.1 in AMGM//PU.1 signifi-abnormalities of secretion of several NFB-regulated
Immunity
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Figure 5. Defective Intracellular Killing of Bacteria in AMs of GM/
Mice and Rescue by PU.1 Expression
Intracellular killing of live gram-negative (E. coli) and gram-positive
(Streptococcus) bacteria was assessed in cultured AMs from GM/
mice (open bar) or AMs from GM/ mice transduced with either a
control vector (black bar) or PU.1-expressing vector (hatched bar)
as indicated and described in Experimental Procedures. Data are
normalized for differences in phagocytic uptake of bacteria. The
height of each bar reflects the ability of bacteria to grow within AMs
(i.e., inversely related to AM killing of bacteria). This experiment was
repeated five times with similar results.
cantly increased dose-dependent TNF
 release at all
doses tested compared to AMGM//GFP (p 0.001). Sim-
ilar results were obtained for peptidoglycan-stimulated
IL-6 release, although the differences in the absence or
presence of PU.1 were less.
Because CD14 expression has been reported to in-
Figure 6. Reduced Cell-Surface Receptor Expression and Inflam-crease as cultured monocytes are induced to differenti-
matory Cytokine Signaling in AMs from GM/ Mice and Rescue byate into macrophages and CD14 is important in TLR
Expression of GM-CSF in the Lung In Vivo or Retrovirus-Mediated
signaling pathways, we assessed the effect of PU.1 in PU.1 Expression In Vitro
regulating CD14 and MyD88 levels in AMs by Western (A) RT-PCR analysis of receptor mRNA in primary AMs and cultured
analysis. CD14 was markedly reduced in AMGM//GFP AMs transduced with control or PU.1-expressing vectors. Total RNA
compared to AMGM//PU.1. In contrast, MyD88 did not was purified from primary or cultured AMs and evaluated by RT-
PCR analysis using gene-specific oligonucleotide primers for mac-differ in these cells (Figure 6C). Taken together, these
rophage mannose receptor (MR), Toll-like receptor (TLR) 4, TLR2,data are consistent with a mechanism by which PU.1
and, as a control, GAPDH.mediates GM-CSF-dependent, pathogen-induced pro-
(B) Assessment of proinflammatory cytokine release by cultured
inflammatory cytokine signaling in AMs via Toll-like re- AMs by ELISA. Cultured AMs transduced with control vector (open
ceptor pathways. bars) or PU.1-expressing vector (black bars) were exposed to LPS
or peptidoglycan at the indicated concentrations for 16 hr, and
supernates were collected and assessed for the presence of TNF
Discussion
or IL-6 as indicated.
(C) Western blot assessment of expression of components of the
The present studies show that AMs of GM/ mice have TLR4 LPS signaling pathway in AM. Cultured AMs from GM/ mice
an abnormal phenotype consistent with incomplete dif- transduced with control vector or PU.1-expressing vector were eval-
uated by Western blotting using anti-murine CD14, anti-murineferentiation and that levels of the transcription factor
MyD88, or anti-murine actin antibodies.PU.1 in AMs correlate precisely with the presence and
level of GM-CSF in the lung. Constitutive PU.1 expres-
sion in AMs of GM/ mice in vitro rescued all of the
phenotypic abnormalities. The effects of GM-CSF and strongly support the conclusion that GM-CSF is a critical
regulator of AM terminal differentiation in the lung andPU.1 on AM differentiation cannot be attributed to stimu-
lation of differentiation by M-CSF because M-CSF levels implicate PU.1 as a principal mediator of this effect. This
conclusion is supported by the prior observation thatwere normally low in the lungs of GM/mice, but were
significantly elevated in the lungs of GM/ mice and PU.1 gene expression can be stimulated by GM-CSF in
both murine (Chen et al., 1995) and human (Voso et al.,were normalized in SPC-GM/GM/ mice. These data
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1994) hematopoietic progenitors. Further, GM-CSF is
known to stimulate survival, proliferation, and differenti-
ation of hematologic progenitors as well as AMs (Aka-
gawa et al., 1988; Chen et al., 1988), and both GM-CSF
and PU.1 stimulate expression of large and overlapping
sets of genes in mononuclear phagocytes (Hashimoto et
al., 1999; Tenen et al., 1997). Recently, lineage-specific
development of hematopoietic progenitors was shown
to be regulated by the level of PU.1 expression, with
high levels directing macrophage differentiation and low
levels directing B cell differentiation (DeKoter and Singh,
2000). This finding, together with our results, suggests
a potential explanation for the pulmonary lymphocytosis
observed in GM/ mice (Dranoff et al., 1994). While
these studies demonstrate that GM-CSF regulates PU.1
levels in AMs, because GM-CSF receptor signaling in-
volves multiple distinct pathways (Sato et al., 1993) fur- Figure 7. Proposed Role of GM-CSF and PU.1 in Regulation of Differ-
entiation and Innate Immune Function of the Alveolar Macrophagether studies will be required to delineate the precise
regulatory pathway(s). Also, because most but not all GM-CSF interacts with macrophage precursors in the lung, stimulat-
ing the “master” myeloid transcription factor PU.1. PU.1 is requiredfunctions of AMs were restored completely by PU.1, our
for terminal differentiation/maturation of AMs, resulting in stimula-data do not rule out contributions from other transcrip-
tion of multiple, diverse, and complex functions that enable maturetion factors which have been implicated in late myeloid
AMs to play critical roles in maintenance of lung homeostasis and
differentiation (Tenen et al., 1997). innate immune host defense.
Several lines of evidence support the conclusion that
local rather than systemic GM-CSF expression is critical
in the regulation of AM differentiation and function in marrow and blood and AM numbers are normal (Dranoff
the lung. First, PAP and AM abnormalities in GM/ mice et al., 1994; Nishinakamura et al., 1996a; Robb et al.,
are corrected by expression of GM-CSF exclusively in 1995). Consistent with this is the finding that PU.1 is not
the lung and by pulmonary but not intravenous adminis- required for early myeloid gene expression or commit-
tration of GM-CSF (Huffman et al., 1996; Reed et al., ment to the myeloid lineage (Henkel et al., 1999;
1999). Second, GM-CSF appears to be tightly compart- McKercher et al., 1999; Olson et al., 1995). The observa-
mentalized between lung and blood because GM-CSF tion that PU.1 alters cell adhesion is supported by the
reaches extraordinary levels in the lungs of SPC-GM/ finding that both GM-CSF and PU.1 are known to regu-
GM/ mice (700 pg/ml BAL), yet is undetectable in late expression of integrins (Feng et al., 1999; Pahl et
the serum of these mice (Huffman Reed et al., 1997). al., 1993), which are important in cell adhesion. Further,
Third, the activity of GM-CSF is also compartmentalized
adherence of monocytes to plastic results in increased
between blood and lung: SPC-GM/GM/ mice have
expression of PU.1, integrin 2 mRNA, and hck (hemato-
greatly increased AM numbers due to markedly elevated
poietic cell kinase) (de Fougerolles et al., 2000). Hck is
GM-CSF levels in the lungs, while blood leukocyte levels
a Src family protein tyrosine kinase expressed in myeloidare normal (Huffman et al., 1996). The latter finding would
cells that appears to act as a molecular switch betweennot be expected if blood levels of GM-CSF were elevated
cell motility and adhesion/spreading in HL60 cells (Chi-(Donahue et al., 1986).
aradonna et al., 1999). Our observation that brief adher-The present study shows that the critical effect of
ence of AMs to plastic dishes resulted in low level PU.1GM-CSF on AMs in vivo is stimulation of their terminal
expression in AMGM/ (Figure 1B) is consistent withdifferentiation. We propose a model in which monocytes
these reports. Because PU.1 positively autoregulates itsentering the lung are exposed to levels of GM-CSF stim-
own transcription (Chen et al., 1995), adherence mayulating increased PU.1 levels, inducing their further dif-
also be further stimulated after initiation by a mechanismferentiation (Figure 7). This model is supported by sev-
involving autoregulation of PU.1 expression. The dem-eral findings. First, multiple, diverse abnormalities in
onstration in AMs of GM/ mice that PU.1 stimulatesunrelated macrophage functions were demonstrated in
uptake and catabolism of both surfactant lipids andAMs of GM/mice, including defects in surfactant lipid
proteins in vitro was an unexpected and novel findingand protein catabolism, cell morphology, cell adhesion,
of this report. This is supported by the observationsexpression of pathogen pattern recognition receptors,
that expression of GM-CSF in the lungs of GM/ micespecific and nonspecific phagocytosis, bacterial killing,
corrects the abnormalities in surfactant catabolism byand Toll-like receptor signaling. Second, all of these
AMs (e.g., in SPC-GM/GM/ mice) and our observationabnormalities could be rescued by forced expression
that GM-CSF regulates PU.1 expression in AMs in vivo.of a single “master” transcription factor, PU.1. Third,
This is also supported by the observation that adherenceextensive data demonstrate that PU.1 plays a predomi-
of normal AMs to plastic results in a 5-fold increase innant role in the terminal differentiation of macrophages
SP-A degradation (Bates and Fisher, 1996). Thus, our(Anderson et al., 1998a, 1999; Olson et al., 1995; Scott
data suggest a molecular mechanism for this observa-et al., 1994). Fourth, despite relevance to AM maturation,
tion involving an adherence-stimulated increase in PU.1GM-CSF likely plays a noncritical role in early myelo-
levels and subsequent effects of PU.1-mediated stimu-poiesis and early AM development, because GM/ and
GM Rc/ mice lack hematologic abnormalities in bone lation of surfactant degradation pathways.
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Isolation, Culture, and Retroviral Transduction of AMsAn important finding of the present study is the dem-
Primary AMs were obtained by bronchoalveolar lavage (BAL) asonstration that PU.1 critically regulates multiple innate
previously described (LeVine et al., 1999). Surfactant lipids and pro-immune functions of AMs. This is supported by the ob-
teins were removed from the cells by sedimentation through PBS
servation that GM-CSF expression in the lungs of GM/ containing 15% bovine serum albumin (BSA), 0.5 mM EDTA (450 
mice (e.g., SPC-GM/GM/ mice) rescues these func- g, 5 min, 4	C) (Sandron et al., 1986). Viability of AMs obtained in
this way was greater than 95% for cells of GM/ and SPC-GM/tions in vivo (LeVine et al., 1999) and our demonstration
GM/ mice as determined by trypan blue staining. Viability of AMsthat GM-CSF regulates PU.1 expression in AMs in vivo.
from GM/ mice was slightly less and was more difficult to evaluateFurther, recombinant GM-CSF stimulates phagocytosis
due to the presence of large amounts of surfactant. Brief (1 hr)
and bacterial killing by macrophages in vitro and in vivo adherence of AMs to plastic minimized this problem. MH-S is an
(Coleman et al., 1988). The MR is a pattern recognition AM cell line with morphologic and functional features of normal
receptor involved in bacterial phagocytosis whose ex- mature AMs, previously derived from normal mice by SV40 transfor-
mation (Mbawuike and Herscowitz, 1989). mAM is an AM cell linepression is dependent on PU.1 (Eichbaum et al., 1997).
previously derived from GM-CSF/ mice by culture in mouse L-929Thus, the observation that MR mRNA is absent in
cell-conditioned media without viral transformation and will be de-AMGM/ and AMGM//GFP and restored in AMSPC-GM/GM/ scribed elsewhere (Z.C.C., unpublished data). Constitutive expres-
and AMGM//PU.1 provides a potential molecular mecha- sion of murine PU.1 was achieved in AMs from GM/ mice by
nism to explain these findings. However, the global and transduction of mAM cells with a retroviral vector expressing murine
PU.1 and, as a selectable marker, also green fluorescent proteinparallel regulation of phagocytosis of gram-negative and
(GFP) (DeKoter and Singh, 2000). As a transduction control, mAMgram-positive bacteria, zymosan, and latex beads sug-
cells expressing only the GFP marker were also prepared. Culturedgests involvement of a more general mechanism. Inter-
AMs were maintained as previously described for culturedestingly, macrophages from hck gene-targeted mice RAW264.7 macrophages (Zsengeller et al., 2000).
show decreased phagocytosis but have normal hemato-
poiesis (Lowell et al., 1994), suggesting that hck may Western Blot Analysis
be an important link in GM-CSF-mediated regulation of Western analysis was performed as previously described (Anderson
et al., 1998b) with primary AMs pooled from three to four mice perphagocytosis downstream of PU.1. gp91phox and p47phox,
group or cultured AMs grown on 100 mm plastic dishes. Primarycomponents of the superoxide-forming phagocyte
antibodies included rabbit anti-murine PU.1 (Santa Cruz, CA) (usedNADPH oxidase complex important in bacterial killing,
at 1:400), goat anti-murine actin (used at 1:200), goat anti-murine
are known to be regulated by PU.1 and thus may provide MyD88 (used at 1:200), or rabbit anti-murine CD14 (used at 1:1600)
a link in GM-CSF-stimulation of microbicidal activity (all from Santa Cruz). Immunoreactive proteins were visualized by
enhanced chemiluminescence (ECL; Amersham, Piscataway, NJ)(Weiser et al., 1987) downstream of PU.1. These data
and exposed to Kodak X-Omat AR film.are consistent with the decrease in superoxide produc-
tion by AMGM/ compared to wild-type AM and the res-
Morphological and Morphometric Analysis of AMscue of this abnormality by expression of GM-CSF in the
Primary AMs collected by BAL without albumin purification or cul-
lung (LeVine et al., 1999). The concept that GM-CSF tured AMs collected by brief trypsinization and washing were sedi-
regulates TLR4 mRNA levels in AMs through PU.1 is mented by cytocentrifugation and evaluated by light microscopy
supported by the observation that PU.1 regulates TLR4 as previously described (Dranoff et al., 1994). Digitally captured
fluorescence photomicrographs were assessed morphometricallypromoter (Rehli et al., 2000). The observation that PU.1
to determine the AM equivalent cell diameter using Metamorphalso regulates TLR2 is a novel finding of the present
software (Universal Imaging Corp., West Chester, PA) on an IBM-study. Stimulation of TNF
 release from macrophages
compatible computer.
by gram-negative bacteria is mediated by a pathway
involving LPS binding protein, CD-14, TLR4, and MyD88, AM Adherence Assay
which ultimately results in NFB and Jun/Fos activation To assess cell adhesion, cultured AMs (106 cells) were seeded in 35
mm standard plastic or ultra low adherence culture dishes (Costar,and increased transcription of multiple immune re-
Corning, NY). After 2 hr, nonadherent cells were removed by aspira-sponse genes (reviewed in Aderem and Ulevitch, 2000).
tion of the media and gently washing twice with PBS. AdherenceThus, our data suggest that PU.1 enables proinflamma-
was measured by counting the number of AMs per 10 power field
tory cytokine signaling by stimulating expression of one in 5 consecutive, randomly selected fields per dish, using six dishes
or more components of this signaling pathway. While per AM line.
regulation of MyD88 does not appear to be involved,
Uptake and Degradation of Surfactant Lipid and SP-A by AMfurther studies will be needed to identify the potentially
The ability of AMs to take up surfactant lipids was assessed usingrate-limiting factors. Taken together, these results dem-
natural surfactant, isolated as described (Ikegami et al., 1996), andonstrate that GM-CSF is a critical regulator of lung ho-
mixed with fluorescently labeled R-DPPE (Avanti Polar Lipids, Ala-
meostasis and innate immunity in the lung and that its baster, AL) as previously described (Yoshida et al., 2001). Degrada-
effects are mediated by coordinate regulation of AM tion of surfactant lipids by AMs was assessed using natural surfac-
gene expression by PU.1. tant (100 g phospholipid/ml suspension) containing 10 Ci/ml
[3H]DPPC (Amersham, Arlington Heights, IL) as previously described
(Yoshida et al., 2001). The ability of cultured AMs to internalize and
Experimental Procedures degrade surfactant protein was evaluated using [125I]-labeled SP-A
as previously described (Yoshida et al., 2001).
Mice
GM/ and SPC-GM/GM/ mice were generated previously (Dra- Phagocytosis Assay
noff et al., 1994; Huffman et al., 1996) and were maintained in the Heat-killed S. aureus, E. coli, or zymosan, as well as 0.1 m latex
C57BL/6 background. C57BL/6 mice (GM/) were from Jackson beads, each fluorescently labeled with Texas red (Molecular Probes,
Laboratories (Bar Harbor, ME). All mice were housed in a pathogen- Eugene, OR), were used to evaluate phagocytosis in cultured AM.
free barrier facility and studied under procedures approved by the Cells were seeded at 106/35 mm dish and incubated with bacteria
or zymosan at a multiplicity of 100/cell or with latex beads at 105/cellInstitutional Animal Care and Use Committee.
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for 2 hr at 37	C. Noninternalized particles were then removed by stimulating factor-1 on the proliferation and differentiation of murine
alveolar macrophages. J. Immunol. 141, 3383–3390.vigorous and extensive washing with PBS, and cells were fixed
in PBS containing 3% paraformaldehyde at 25	C for 15 min and Anderson, K.L., Smith, K.A., Conners, K., McKercher, S.R., Maki,
evaluated by fluorescence microscopy as previously described R.A., and Torbett, B.E. (1998a). Myeloid development is selectively
(Zsengeller et al., 2000). To quantify phagocytic uptake in cultured disrupted in PU.1 null mice. Blood 91, 3702–3710.
AM, cells were incubated with FITC-labeled 0.1 m latex beads
Anderson, K.L., Smith, K.A., Pio, F., Torbett, B.E., and Maki, R.A.(Molecular Probes) and washed as above. Cells were then detached
(1998b). Neutrophils deficient in PU.1 do not terminally differentiateby brief trypsinization and evaluated by flow cytometry on a FAC-
or become functionally competent. Blood 92, 1576–1585.SCAN flow cytometer (Becton Dickinson, Franklin Lakes, NJ). All
Anderson, K.L., Smith, K.A., Perkin, H., Hermanson, G., Anderson,experiments were done in duplicate.
C.G., Jolly, D.J., Maki, R.A., and Torbett, B.E. (1999). PU.1 and the
granulocyte- and macrophage colony-stimulating factor receptorsAM Killing of Live Bacteria
play distinct roles in late-stage myeloid cell differentiation. BloodBacterial uptake and killing by cultured AMs was assessed as pre-
94, 2310–2318.viously described (Gjomarkaj et al., 1999) using E. coli (DH5
; Life
Technologies, Gaithersburg, MD) or group B Streptococcus (ob- Arnaout, M.A., Wang, E.A., Clark, S.C., and Sieff, C.A. (1986). Human
tained as a clinical isolate from a newborn infant with systemic recombinant granulocyte-macrophage colony-stimulating factor in-
infection [LeVine et al., 1999]). Bacteriocidal activity was calculated creases cell-to-cell adhesion and surface expression of adhesion-
from the number of live bacteria within AMs normalized for the promoting surface glycoproteins on mature granulocytes. J. Clin.
phagocytic index of each and expressed as a bacterial growth index Invest. 78, 597–601.
according to the following formula: growth index (GI)  {(bacterial
Basu, S., Dunn, A.R., Marino, M.W., Savoia, H., Hodgson, G.,
colonies/ml AM cell lysate)/phagocytic index} 100. The phagocytic
Lieschke, G.J., and Cebon, J. (1997). Increased tolerance to endo-
index (PI) was determined by assessing 200 consecutive AMs under
toxin by granulocyte-macrophage colony-stimulating factor-defi-
80magnification for the presence and number of bacteria using the
cient mice. J. Immunol. 159, 1412–1417.
following formula: PI (number of AM) (% of AMs with bacteria)
Bates, C.R., and Fisher, A.B. (1996). Surfactant protein A is degraded(mean number of bacteria/AM).
by alveolar macrophages. Am. J. Physiol. 271, L258–L266.
TNF and IL-6 Release Assays Celada, A., Borras, F.E., Soler, C., Lloberas, J., Klemsz, M., van
Cultured AMs seeded at 2  105/well in 24-well plates (Costar) in Beveren, C., McKercher, S., and Maki, R.A. (1996). The transcription
DMEM containing 10% FBS were exposed to either LPS (S. typhi- factor PU.1 is involved in macrophage proliferation. J. Exp. Med.
rium; Sigma, Saint Louis, MO) at 0.1, 1.0, and 10 ng/ml, or peptido- 184, 61–69.
glycan (Fluka, Milwaukee, WI) at 0.1, 1.0, and 10 g/ml for 16 hr. Chen, B.D., Mueller, M., and Chou, T.H. (1988). Role of granulocyte/
AM cell supernatants were then collected, cleared of debris by macrophage colony-stimulating factor in the regulation of murine
centrifugation, and TNF
 or IL-6 levels were quantified using murine alveolar macrophage proliferation and differentiation. J. Immunol.
Quantikine kits (R & D, Minneapolis, MN) as directed by the manufac- 141, 139–144.
turer. All assays were done in triplicate.
Chen, H.M., Zhang, P., Voso, M.T., Hohaus, S., Gonzalez, D.A.,
Glass, C.K., Zhang, D.E., and Tenen, D.G. (1995). Neutrophils andIsolation of RNA and RT-PCR Analysis
monocytes express high levels of PU.1 (Spi-1) but not Spi-B. BloodReverse transcriptase-polymerase chain reaction (RT-PCR) analysis
85, 2918–2928.was performed as previously described (Otake et al., 1998) using the
Chiaradonna, F., Fontana, L., Iavarone, C., Carriero, M.V., Scholz,following primer sets: glyceraldehyde 3 phosphate dehydrogenase
G., Barone, M.V., and Stoppelli, M.P. (1999). Urokinase receptor-(GAPDH; 5-ATTCTACCCACGGCAAGTTCAATGG-3; 5-AGGGGC
dependent and -independent p56/59(hck) activation state is a mo-GGAGATGATGACCC -3), TLR2 (5-CCTTTGTTTCCTACAGTGAG
lecular switch between myelomonocytic cell motility and adherence.CAGG-3; 5-TCCTGCTGGCCTTCATCCAAGG-3), TLR-4 (5-TACT
EMBO J. 18, 3013–3023.CGAGTCAGAATGAGGACTGG-3; 5-TTCGAGGCTTTTCCATCCAA
TAGG-3), macrophage mannose receptor (5-CGGAAGCTGAATCC Chroneos, Z., and Shepherd, V.L. (1995). Differential regulation of
CAGAAATTCC-3; 5-GAATGGAAATGCACAGACGGCTCC-3). the mannose and SP-A receptors on macrophages. Am J. Physiol.
269, L721–L726.
Statistical Analyses
Coleman, D.L., Chodakewitz, J.A., Bartiss, A.H., and Mellors, J.W.
Numerical data are presented as mean  SEM. Statistical compari-
(1988). Granulocyte-macrophage colony-stimulating factor en-
sons were performed using Student’s t test with Sigma Plot 4.0
hances selective effector functions of tissue-derived macrophages.
software on an IBM-compatible microcomputer. Statistical signifi-
Blood 72, 573–578.
cance was taken at p  0.05.
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